This is a StreetInsider.com Premium Only Page

Immunogen (IMGN) – StreetInsider.com Reports

Feb 12, 2024 07:38 AM AbbVie (ABBV) Completes Acquisition of ImmunoGen (IMGN)

Dec 11, 2023 03:52 AM Immunogen (IMGN) Presents Findings from Newly Diagnosed Acute Myeloid Leukemia Cohorts in Phase 1b/2 Study of Pivekimab Sunirine in Combination with Azacitidine and Venetoclax

Dec 5, 2023 06:33 AM Immunogen (IMGN) sBLA for ELAHERE granted priority review from FDA

Dec 4, 2023 03:52 AM Barclays Downgrades Immunogen Inc. (IMGN) to Equalweight

Dec 3, 2023 11:29 PM Piper Sandler Downgrades Immunogen Inc. (IMGN) to Neutral

Dec 1, 2023 12:17 PM Barclays Downgrades Immunogen Inc. (IMGN) to Equalweight

Dec 1, 2023 04:03 AM Increasing unusual put option volume: BMBL IMGN BROS DELL FTCH JBL RILY PSTG ESTC

Dec 1, 2023 12:40 AM Guggenheim Downgrades Immunogen Inc. (IMGN) to Neutral

Nov 30, 2023 04:20 PM BMO Capital Downgrades Immunogen Inc. (IMGN) to Market Perform

Nov 30, 2023 03:41 PM Deutsche Bank Downgrades Immunogen Inc. (IMGN) to Hold

Nov 30, 2023 01:17 PM Jefferies Downgrades Immunogen Inc. (IMGN) to Hold

Nov 30, 2023 12:12 PM Midday movers: Snowflake, Salesforce, and more

Nov 30, 2023 11:58 AM Canaccord Genuity Downgrades Immunogen Inc. (IMGN) to Hold

Nov 30, 2023 10:52 AM Immunogen (IMGN) option IV after AbbVie (ABBV) to acquire

Nov 30, 2023 10:37 AM H.C. Wainwright Downgrades Immunogen Inc. (IMGN) to Neutral

Nov 30, 2023 10:01 AM Increasing unusual put option volume: HASI IMGN PSTG ASO CPNG LYV FRO CRM HRL EWU

Nov 30, 2023 09:46 AM William Blair Downgrades Immunogen Inc. (IMGN) to Market Perform

Nov 30, 2023 09:36 AM Truist Securities Downgrades Immunogen Inc. (IMGN) to Hold

Nov 30, 2023 09:27 AM Immunogen (IMGN) shares surge on news of takeover by AbbVie (ABBV)

Nov 30, 2023 07:55 AM Immunogen (IMGN) call put ratio 22 calls to 1 put into AbbVie (ABBV) to acquire

Nov 30, 2023 07:45 AM AbbVie seeks lift from 'guided missile' cancer drug with $10 billion ImmunoGen deal

Nov 30, 2023 07:45 AM Sutro Biopharma (STRO) Trades Higher in Sympathy with Immunogen (IMGN)

Nov 30, 2023 07:41 AM Immunogen (IMGN) to Resume Trading at 8 a.m. Following News of Takeover by AbbVie (ABBV)

Nov 30, 2023 07:31 AM AbbVie (ABBV) to Acquire ImmunoGen (IMGN) for $31.26 Per Share, $10.1 Billion

Nov 30, 2023 07:27 AM Immunogen (IMGN) Halted, News Pending

Nov 20, 2023 04:28 AM Goldman Sachs Starts Immunogen Inc. (IMGN) at Neutral

Nov 9, 2023 02:40 AM Deutsche Bank Starts Immunogen Inc. (IMGN) at Buy

Nov 3, 2023 06:44 AM Immunogen Inc. (IMGN) PT Raised to $28 at H.C. Wainwright

Nov 2, 2023 06:33 AM Immunogen (IMGN) Tops Q3 EPS by 6c

Oct 27, 2023 06:30 AM Immunogen (IMGN) Announces EU Acceptance of Marketing Authorization Application for Mirvetuximab Soravtansine

Oct 26, 2023 07:53 AM This biotech stock is seen as the next takeover with over 100% upside

Oct 9, 2023 08:54 AM Piper Sandler highlights 12 biotech takeover targets as M&A 'about as conducive as we've seen'

Oct 5, 2023 04:13 PM Oppenheimer Starts Immunogen (IMGN) at Perform, "anticipate shares to continue trading near fair value"

Sep 28, 2023 07:02 AM Immunogen (IMGN) Announces ELAHERE Shows Overall and PFS Benefit Regardless of Prior PARPi Exposure or Prior Lines of Therapy in FRα-Positive Platinum-Resistant Ovarian Cancer

Sep 18, 2023 06:30 AM Immunogen (IMGN) Appoints Lauren White as CFO

Sep 13, 2023 05:19 AM JPMorgan Upgrades Immunogen Inc. (IMGN) to Overweight

Aug 29, 2023 06:34 AM Immunogen Inc. (IMGN) PT Raised to $27 at H.C. Wainwright

Aug 28, 2023 06:30 AM Immunogen (IMGN) Collaborates with Takeda (TAK) to Develop and Commercialize ELAHERE in Japan

Aug 2, 2023 05:40 AM Immunogen Inc. (IMGN) PT Raised to $27 at Barclays

Aug 1, 2023 07:34 AM Immunogen Inc. (IMGN) PT Raised to $25 at Canaccord Genuity

Aug 1, 2023 06:43 AM Immunogen Inc. (IMGN) PT Raised to $26 at H.C. Wainwright

Aug 1, 2023 06:36 AM Immunogen Inc. (IMGN) PT Raised to $26 at BMO Capital

Jul 31, 2023 06:35 AM Immunogen (IMGN) Announces Departure of Chief Medical Officer

Jul 31, 2023 06:30 AM Immunogen (IMGN) Tops Q2 EPS by 11c

Jul 27, 2023 08:15 AM Immunogen Inc. (IMGN) PT Raised to $23 at Canaccord Genuity

Jul 24, 2023 06:31 AM Immunogen (IMGN) Enters Multi-Target License and Option Agreement with ImmunoBiochem to Develop Next-Generation Antibody-Drug Conjugates

Jun 13, 2023 06:32 AM Immunogen Inc. (IMGN) PT Raised to $21 at H.C. Wainwright

Jun 12, 2023 04:16 AM Immunogen Inc. (IMGN) PT Raised to $20 at Barclays

Jun 9, 2023 10:01 AM ImmunoGen shares jump after Barclays raises price target of biotech firm

Jun 9, 2023 09:06 AM Immunogen Inc. (IMGN) PT Raised to $20 at Barclays, 'KOL commentary suggested the drug is likely practice changing'